MXD3 and central nervous system cancer: Moreover, the MXD3 expression levels were correlated with overall survival (Fig. 14D–H) in 3/4 of the glioma cohorts (Nutt_Glioma@PRECOG, TCGA, and GSE16011@PRECOG) and likewise with CTL levels (Fig. 14D–H) in 3/4 of the glioma cohorts (ca00037@PRECOG, TCGA, and GSE16011@PRECOG).